The unseen costs of the proposed Dow-DuPont merger are certain to be much larger than those we can currently describe. Both companies will effectively be more reactive to external developments, rather than pro-active, due to the internal focus that will be required to develop and implement the merger and divestment processes. This cost could well […]
Tag Archives | DuPont
All the evidence suggests that most mergers fail to deliver the promised value. So those who propose them, especially when they involve such critical companies for the US and global economy as Dow Chemical and DuPont, must expect some hard questions to be asked. Here are my 5 top questions in logical order – Why?, […]
By now, companies should be reordering for the New Year. CFOs have achieved their working capital targets for year-end. And the commercial people should be planning Q1 sales. So far, however, it seems that this restocking has proved rather weak. This parallels September’s disappointment, when the return from the summer holidays also failed to produce […]
Financial markets are different from other markets. And the way we relate to them is different too. Shops, for example, would never seek to win new customers by advertising ‘Prices increased 10% last week’. Instead, they splash red signs across their windows featuring their ‘new, lower prices’. But sellers of financial products do the exact […]
In the Boom period, it was the investment bankers who used to walk away with telephone number fees, after convincing a CEO to go after an acquisition ‘opportunity’. Now, in another sign of the New Normal, it is a former quality control manager who has become $96m richer, after making a ‘whistleblower’ call to GlaxoSmithKline’s […]
The blog is pleased to have been invited by the American Chemical Society (ACS) to join its online panel discussion on “Chemical Industry & Employment Outlook: Trends 2010 and Beyond”, taking place via webinar on Tuesday 2 November. Its co-panellists will be Pat Confalone, Vice-President, Global R&D, Du Pont; and Susan Butts, Senior Director of […]
The blog has come across a useful new tool for global brainstorming, run out of San Francisco by DiscoveryCast. They have recently organised a major event with Paris-based SpecialChem to review the current state of play in bio-based initiatives. This involved a group of 550 experts from 400 companies (including 3M, Dow, Michelin, DuPont, Arkema, […]
The blog’s quarterly survey of company Outlook statements shows CEOs remain very cautious. There has been a rebound after the destocking disaster of Q4 2008 – Q1 2009. But there seems little confidence that we will quickly return to the levels of demand and margin seen in the 2003-7 Boom period. China’s stimulus and loan […]
Over the past century, many parts of the world have seen an extraordinary increase in living standards and life expectancy. As the Financial Times notes, we used to marry at c15 years, become grandparents at c30 and die at c45. Yet whilst 15 – 30 – 45 is still the demographic cycle in the poorest […]
This week’s company results have been keenly awaited, as the industry seeks to form a view on what happens next to demand and profits. My new IeC colleague Paul Satchell reviews them, from the point of view of a highly-experienced financial analyst, in his ‘Chemicals Viewpoint’. But the blog thought it would also be interesting […]
FREE TRIAL TO ICIS NEWS
LATEST CHEMICAL INDUSTRY NEWS
Paul Hodges is Chairman of International eChem, trusted commercial advisers to the global chemical industry.
The aim of this blog is to share ideas about the influences that may shape the chemical industry over the next 12 – 18 months. It will try to look behind today’s headlines, to understand what may happen next in important issues such as oil prices, economic growth and the environment. We may also have some fun, investigating a few of the more offbeat events that take place from time to time. Please do join me and share your thoughts.
Between us, we will hopefully develop useful insights into the key factors that will drive the industry's future performance.